Actively Recruiting
Study of Hydrochlorothiazide to Support Tolvaptan Treatment and Improve Quality of Life in Adults with ADPKD
Led by University Medical Center Groningen · Updated on 2026-08-25
300
Participants Needed
25
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Autosomal dominant polycystic kidney disease ADPKD is a condition where kidney cysts progressively form and lead to declining kidney function. Researchers are evaluating whether adding hydrochlorothiazide HCT can improve the effectiveness and tolerability of tolvaptan, the only current treatment for preserving kidney function in ADPKD. This Phase 3 randomized, placebo-controlled trial aims to enroll around 300 adults with ADPKD who are already on a stable dose of tolvaptan. Participants will be randomly assigned to receive either oral hydrochlorothiazide 25 mg once daily or a matching placebo for 156 weeks. The study involves regular visits every 12 weeks, which align with routine care for tolvaptan-treated patients, plus an extra visit or phone call two weeks after starting the study drug. The trial is designed to assess whether co-treatment with HCT can slow kidney function decline and improve quality of life compared to placebo. During the study, participants will undergo kidney function tests, including measurements of estimated glomerular filtration rate eGFR, urine volume, and various blood chemistry tests. Quality of life will be assessed with several questionnaires. Researchers will also monitor V2 receptor antagonist dosing changes, adverse events, and kidney-related outcomes. The total participation time spans about three years, with assessments continuing 12 weeks after treatment ends to evaluate long-term effects.
CONDITIONS
Brief Title
HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life
Research Team
D
Dr. E Meijer
T
T. Bais, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here